Danaher Corp
DHR: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$412.00 | Szlcnbf | Trhswrcbp |
Danaher Earnings: Reset and China Challenges May Remain High in 2024
As previewed at a recent investor conference, narrow-moat Danaher turned in strong fourth-quarter 2023 results on the strength of its Cepheid diagnostic operations. However, its forecast for 2024 looks weaker than we anticipated with continued softness expected especially in early 2024 when comparable periods look tough. While disappointing, we are not changing our long-term expectations or $243 fair value estimate materially for Danaher.